In the armadillo model, recombinant armadillo IFN-γ (rDnIFN-γ) activates macrophages and improves the control of intracellular pathogens, providing a species-relevant platform for developing leprosy immunotherapy (Peña et al., 2008). This evidence concerns the gene IFNG and leprosy.